purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurological Drugs
1.2 Key Market Segments
1.2.1 Neurological Drugs Segment by Type
1.2.2 Neurological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurological Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Neurological Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurological Drugs Market Competitive Landscape
3.1 Global Neurological Drugs Sales by Manufacturers (2019-2024)
3.2 Global Neurological Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Drugs Sales Sites, Area Served, Product Type
3.6 Neurological Drugs Market Competitive Situation and Trends
3.6.1 Neurological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurological Drugs Industry Chain Analysis
4.1 Neurological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurological Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurological Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Drugs Sales Market Share by Type (2019-2024)
6.3 Global Neurological Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Drugs Price by Type (2019-2024)
7 Neurological Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Drugs Market Sales by Application (2019-2024)
7.3 Global Neurological Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Drugs Sales Growth Rate by Application (2019-2024)
8 Neurological Drugs Market Segmentation by Region
8.1 Global Neurological Drugs Sales by Region
8.1.1 Global Neurological Drugs Sales by Region
8.1.2 Global Neurological Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Neurological Drugs Basic Information
9.1.2 Pfizer Neurological Drugs Product Overview
9.1.3 Pfizer Neurological Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Neurological Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Ely Lilly
9.2.1 Ely Lilly Neurological Drugs Basic Information
9.2.2 Ely Lilly Neurological Drugs Product Overview
9.2.3 Ely Lilly Neurological Drugs Product Market Performance
9.2.4 Ely Lilly Business Overview
9.2.5 Ely Lilly Neurological Drugs SWOT Analysis
9.2.6 Ely Lilly Recent Developments
9.3 Actavis
9.3.1 Actavis Neurological Drugs Basic Information
9.3.2 Actavis Neurological Drugs Product Overview
9.3.3 Actavis Neurological Drugs Product Market Performance
9.3.4 Actavis Neurological Drugs SWOT Analysis
9.3.5 Actavis Business Overview
9.3.6 Actavis Recent Developments
9.4 Mylan
9.4.1 Mylan Neurological Drugs Basic Information
9.4.2 Mylan Neurological Drugs Product Overview
9.4.3 Mylan Neurological Drugs Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 Randox
9.5.1 Randox Neurological Drugs Basic Information
9.5.2 Randox Neurological Drugs Product Overview
9.5.3 Randox Neurological Drugs Product Market Performance
9.5.4 Randox Business Overview
9.5.5 Randox Recent Developments
9.6 Intellipharmaceutics
9.6.1 Intellipharmaceutics Neurological Drugs Basic Information
9.6.2 Intellipharmaceutics Neurological Drugs Product Overview
9.6.3 Intellipharmaceutics Neurological Drugs Product Market Performance
9.6.4 Intellipharmaceutics Business Overview
9.6.5 Intellipharmaceutics Recent Developments
9.7 Astrazeneca
9.7.1 Astrazeneca Neurological Drugs Basic Information
9.7.2 Astrazeneca Neurological Drugs Product Overview
9.7.3 Astrazeneca Neurological Drugs Product Market Performance
9.7.4 Astrazeneca Business Overview
9.7.5 Astrazeneca Recent Developments
9.8 Lundbeck
9.8.1 Lundbeck Neurological Drugs Basic Information
9.8.2 Lundbeck Neurological Drugs Product Overview
9.8.3 Lundbeck Neurological Drugs Product Market Performance
9.8.4 Lundbeck Business Overview
9.8.5 Lundbeck Recent Developments
9.9 Allergan
9.9.1 Allergan Neurological Drugs Basic Information
9.9.2 Allergan Neurological Drugs Product Overview
9.9.3 Allergan Neurological Drugs Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 GSK
9.10.1 GSK Neurological Drugs Basic Information
9.10.2 GSK Neurological Drugs Product Overview
9.10.3 GSK Neurological Drugs Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Otsuka Pharmaceutical
9.11.1 Otsuka Pharmaceutical Neurological Drugs Basic Information
9.11.2 Otsuka Pharmaceutical Neurological Drugs Product Overview
9.11.3 Otsuka Pharmaceutical Neurological Drugs Product Market Performance
9.11.4 Otsuka Pharmaceutical Business Overview
9.11.5 Otsuka Pharmaceutical Recent Developments
9.12 Takeda
9.12.1 Takeda Neurological Drugs Basic Information
9.12.2 Takeda Neurological Drugs Product Overview
9.12.3 Takeda Neurological Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 NHU Group
9.13.1 NHU Group Neurological Drugs Basic Information
9.13.2 NHU Group Neurological Drugs Product Overview
9.13.3 NHU Group Neurological Drugs Product Market Performance
9.13.4 NHU Group Business Overview
9.13.5 NHU Group Recent Developments
9.14 Shionogi
9.14.1 Shionogi Neurological Drugs Basic Information
9.14.2 Shionogi Neurological Drugs Product Overview
9.14.3 Shionogi Neurological Drugs Product Market Performance
9.14.4 Shionogi Business Overview
9.14.5 Shionogi Recent Developments
9.15 APOTEX
9.15.1 APOTEX Neurological Drugs Basic Information
9.15.2 APOTEX Neurological Drugs Product Overview
9.15.3 APOTEX Neurological Drugs Product Market Performance
9.15.4 APOTEX Business Overview
9.15.5 APOTEX Recent Developments
9.16 North China Pharmaceutical
9.16.1 North China Pharmaceutical Neurological Drugs Basic Information
9.16.2 North China Pharmaceutical Neurological Drugs Product Overview
9.16.3 North China Pharmaceutical Neurological Drugs Product Market Performance
9.16.4 North China Pharmaceutical Business Overview
9.16.5 North China Pharmaceutical Recent Developments
9.17 Harbin Pharmaceutical Co., Ltd.
9.17.1 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Basic Information
9.17.2 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Overview
9.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Market Performance
9.17.4 Harbin Pharmaceutical Co., Ltd. Business Overview
9.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments
9.18 Lukang Pharmaceutical
9.18.1 Lukang Pharmaceutical Neurological Drugs Basic Information
9.18.2 Lukang Pharmaceutical Neurological Drugs Product Overview
9.18.3 Lukang Pharmaceutical Neurological Drugs Product Market Performance
9.18.4 Lukang Pharmaceutical Business Overview
9.18.5 Lukang Pharmaceutical Recent Developments
9.19 Kelun Pharmaceutical
9.19.1 Kelun Pharmaceutical Neurological Drugs Basic Information
9.19.2 Kelun Pharmaceutical Neurological Drugs Product Overview
9.19.3 Kelun Pharmaceutical Neurological Drugs Product Market Performance
9.19.4 Kelun Pharmaceutical Business Overview
9.19.5 Kelun Pharmaceutical Recent Developments
9.20 Kehua Biology
9.20.1 Kehua Biology Neurological Drugs Basic Information
9.20.2 Kehua Biology Neurological Drugs Product Overview
9.20.3 Kehua Biology Neurological Drugs Product Market Performance
9.20.4 Kehua Biology Business Overview
9.20.5 Kehua Biology Recent Developments
10 Neurological Drugs Market Forecast by Region
10.1 Global Neurological Drugs Market Size Forecast
10.2 Global Neurological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Drugs Market Size Forecast by Region
10.2.4 South America Neurological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurological Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Drugs by Type (2025-2030)
11.1.2 Global Neurological Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Drugs by Type (2025-2030)
11.2 Global Neurological Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Neurological Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings